Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(20 sites)

Israel

Bnai Zion Medical Center, Haifa

Shaare-Zedek Medical Center, Jerusalem

Ziv Medical Center, Safed

Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan

Ospedale dei Bambini "V. Buzzi", Milan

Azienda Ospedale Università di Padova, Padova

Spain

Hospital General Universitario de Alicante Dr. Balmis, Alicante

Hospital Clínic de Barcelona, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona

Hospital Sant Joan de Déu, Barcelona

Hospital Universitario Cruces - OSI Ezkerraldea-Enkarterri-Cruces, Bilbao

Hospital Universitario Puerta del Mar, Cadiz

Hospital Universitari Arnau de Vilanova de Lleida, Lleida

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Universitario La Paz, Madrid

Hospital Regional Universitario de Málaga, Málaga

Hospital Clínico Universitario de Santiago, Santiago de Compostela

Hospital Universitari i Politècnic La Fe, Valencia

Hospital Universitario Miguel Servet, Zaragoza